PLUS1
3.78
-0.25 (-6.2%)
-0.25 (-6.2%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Synlogic Inc | SYBX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.25 | -6.2% | 3.78 | 18:37:19 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.95 | 3.70 | 4.10 | 3.78 | 4.03 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.62 | 3.78 | 0.16 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,618 | 593,593 | $ 3.97 | $ 2,357,151 | 2,670,586 | 1.35 - 4.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:58:59 | 10 | $ 3.78 | USD |
Synlogic Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 131.67M | 34.83M | 18.85M | $ 2.22M | $ - | -1.72 | -2.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Synlogic News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/11/2021 | 06:30 | PR Newswire (US) | Synlogic Outlines Upcoming Clinical Milestones |
| 1/05/2021 | 18:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/14/2020 | 06:00 | PR Newswire (US) | Synlogic Announces Advancement of SYNB1891 to Combination.. |
| 12/10/2020 | 06:01 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 12/09/2020 | 17:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/09/2020 | 16:58 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) |
| 12/09/2020 | 06:30 | PR Newswire (US) | Synlogic Appoints Michael Heffernan to its Board of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SYBX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.85 | 4.30 | 3.55 | 4.07 | 638,632 | -0.07 | -1.82% |
| 1 Month | 2.11 | 4.30 | 2.08 | 3.20 | 2,767,920 | 1.67 | 79.15% |
| 3 Months | 1.87 | 4.30 | 1.81 | 2.76 | 2,117,862 | 1.91 | 102.14% |
| 6 Months | 2.26 | 4.30 | 1.78 | 2.71 | 1,015,872 | 1.52 | 67.26% |
| 1 Year | 2.65 | 4.30 | 1.35 | 2.57 | 682,809 | 1.13 | 42.64% |
| 3 Years | 9.90 | 14.59 | 1.35 | 3.78 | 350,638 | -6.12 | -61.82% |
| 5 Years | 10.30 | 23.00 | 1.35 | 3.93 | 314,542 | -6.52 | -63.3% |
Synlogic Description
| Synlogic Inc is a biopharmaceutical company focused on advancing the drug discovery and development platform for Synthetic Biotic medicines, which are designed using synthetic biology to genetically reprogram beneficial microbes to treat metabolic and inflammatory diseases and cancer. |
